Stay updated on Dupilumab in ABPA Treatment Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.

Latest updates to the Dupilumab in ABPA Treatment Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check36 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check65 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.1%
- Check79 days agoChange DetectedThe page has undergone significant revisions, including the removal of detailed study objectives and key inclusion/exclusion criteria for a clinical trial on dupilumab for Allergic Bronchopulmonary Aspergillosis, while adding a new version number and collaborators.SummaryDifference20%
- Check86 days agoChange DetectedThe webpage has updated its version from v2.14.3 to v2.14.4 and added new helpful links provided by Regeneron Pharmaceuticals. Additionally, several past dates have been removed.SummaryDifference1%
Stay in the know with updates to Dupilumab in ABPA Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.